Home »
» With Promise of Legalization, Psychedelic Companies Joust Over Future Profits
October 25, 2022
https://ift.tt/QrR7YNV
Cash rich start-ups are filing scores of patent claims on hallucinogens like magic mushrooms. Researchers and patient advocates worry high prices will make the therapies unaffordable.
Source link
source
https://financetin.com/with-promise-of-legalization-psychedelic-companies-joust-over-future-profits/financetin.com
Related Posts:
Eucalyptus Oil May Reduce Inflammatory Reactions in LungsEucalyptus is a genus of plants that contains more than 900 species.1 The plants are native to Australia and come in a number of sizes, from shrubs to tall trees. They’re known for growing rapidly: One of the largest is the g… Read More
Vitamin D in the Prevention of COVID-19
As noted by retired nursing teacher John Campbell1 in the video above, vitamin D is "an important immunological molecule" that likely plays role in the COVID-19 pandemic.
In his video commentary, Campbell reviews a number of… Read More- Weekly Health Quiz: Viral Shedding and Exercise
1 Which of the following is a major risk factor for vitamin D deficiency and severe COVID-19?
High melanin density (darker skin)
Darker skin requires far more sun exposure to produce adequate vitamin D, so much so that dar… Read More
- Can UV Light Inactivate Airborne Human Coronavirus?December 31, 2019, China reported a case of pneumonia from an unknown cause to the World Health Organization.1 It wasn't long afterward that it became apparent that the "unknown cause" would create global havoc.
Immediately, … Read More
This Fat Impairs Immune System and Increases Risk of COVID
In this interview, Dr. Chris Knobbe, an ophthalmologist, discusses some of the eye-opening information found in his book, “Ancestral Dietary Strategy to Prevent and Treat Macular Degeneration.”1
Knobbe is the founder and pre… Read More
0 comments:
Post a Comment